about
Hypoparathyroidism: Replacement Therapy with Parathyroid HormoneTherapy of hypoparathyroidism by replacement with parathyroid hormoneBone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT.The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial.Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in HypoparathyroidismPTH replacement therapy of hypoparathyroidism.Melatonin and the skeleton.The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study.Pseudohypoparathyroidism - epidemiology, mortality and risk of complications.Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women.Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study.Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections.BMD improvements after operation for primary hyperparathyroidism.Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings - a case-control study.Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study.Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in Hypothyroidism.No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial.Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial.Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidism.Arterial Stiffness and Central Hemodynamics in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine.Inverse Correlation at the Hip Between Areal Bone Mineral Density Measured by Dual-Energy X-ray Absorptiometry and Cortical Volumetric Bone Mineral Density Measured by Quantitative Computed Tomography.PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial.Dental Findings in Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism: A Systematic Review.Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled TrialEffects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trialThe effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trialChanges in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): A randomized controlled studyHealth-related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidismThe effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled studyMelatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trialVitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialEffects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case seriesPrevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control StudyEffects of Vitamin D3 Supplementation on Muscle Strength, Mass, and Physical Performance in Women with Vitamin D Insufficiency: A Randomized Placebo-Controlled TrialPredictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control StudyCardiovascular findings in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism: A cohort studyHealth-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort studyDental anomalies and orthodontic characteristics in patients with pseudohypoparathyroidism
P50
Q26782156-E4D9B2B7-A79C-4A70-84CC-9A5A998CA947Q26828582-00EEDD1A-1026-41DD-8631-3DC58009E7AFQ35890476-50CD5DAC-64CC-4EB1-A982-63BA9ABF1682Q36111903-E2D889EF-089A-4903-B85A-33F885A9E550Q37475356-A0373165-E60B-415A-92C5-77169C789FACQ38062849-C93E90A3-9DD0-4EB0-BC2A-9646724CDBABQ38110221-724E6F41-CB55-4477-BD84-1E349E1E0FB6Q38370979-71CE55BF-7C55-404B-BCC5-49B1EF1333FFQ40521417-FA8B610E-1D31-4D8F-BEE7-357178C38787Q40622007-70A71DB2-5EC8-4FBC-88FA-695246C4C739Q43477256-73FB65E7-BF60-4842-9DE8-E9B31A95A439Q43987600-71B75A55-2E11-4910-B2ED-4C0D17AA1181Q44217990-A4A1E868-F87B-4C8A-B442-5FCD66D8BE25Q47242754-53426D35-B223-45AB-A1F3-34D51DE4CFEEQ47683848-B4BFA765-61D6-4C1F-8393-3F3354096FBAQ47829069-AC4C62F1-4B99-4D41-8F5C-8B8CEA43C0B4Q48050902-D02FE473-9D87-4B5A-8A52-04AF87ECD719Q48081325-CC1DDA40-F549-4C85-98F8-90922C482497Q48156628-620007FD-5027-40A3-8673-0B50A2574106Q50865509-42954F87-82EC-4D26-9DCA-C67510B364C7Q50956747-66CFF199-7416-4A4F-96DA-51CF8CB0A528Q51221582-EFF9390A-7E6F-4C72-98FC-AA96441F364DQ53357194-E2D75AC7-C533-4435-BFEA-8D1C8368711CQ55437922-EA9E1FFA-B6C8-41F6-B8A9-E9F3A725CF2AQ57183252-0AA0CEE4-0EE4-47EC-AEC9-841AF572FE0CQ59106767-4EC9D82B-561C-4D61-BAF8-49F50CD943F7Q60585716-779C322F-784C-4EF1-BF25-BB9916E05139Q63199345-A99377AE-A9B3-48FA-957B-1FC5E8CD6DE4Q64046097-FF19EEDD-A47B-4A01-B3C6-EBF33CD2F87EQ84578369-B0332B17-E112-4CE0-A10F-C1A8F7CA536CQ85280944-C36A8435-2673-45F9-A998-FC142F0A4055Q87095726-25B9FC51-B4C7-4DC8-8864-3A0411001CA2Q87490473-52978A48-101F-4CF1-857A-107B8A3F67C5Q88592162-1AA785E6-026F-4396-99DF-8790CD863B7FQ89184059-9DAB2B13-6B8A-4BA8-BEE6-76F6A09C87D6Q89338020-A4943947-A2F9-4C7F-856E-77D7E9484913Q90776381-D46B4163-2688-484C-9A1C-CAF342774085Q91866123-D49CF829-BF4B-4211-A260-955FD80025E7Q92354923-09E1FB4A-8148-4E33-9796-1C837CC9F212
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tanja Sikjaer
@ast
Tanja Sikjaer
@en
Tanja Sikjaer
@es
Tanja Sikjaer
@nl
Tanja Sikjaer
@sl
type
label
Tanja Sikjaer
@ast
Tanja Sikjaer
@en
Tanja Sikjaer
@es
Tanja Sikjaer
@nl
Tanja Sikjaer
@sl
prefLabel
Tanja Sikjaer
@ast
Tanja Sikjaer
@en
Tanja Sikjaer
@es
Tanja Sikjaer
@nl
Tanja Sikjaer
@sl
P1053
B-6183-2018
P106
P21
P31
P3829
P496
0000-0002-9074-9570